Previous Page  5 / 20 Next Page
Information
Show Menu
Previous Page 5 / 20 Next Page
Page Background

Notes:

Page 28

Parkinsons 2016

December 05-07, 2016

Volume 6 Issue 6(Suppl)

J Alzheimers Dis Parkinsonism

ISSN: 2161-0460 JADP, an open access journal

conferenceseries

.com

December 05-07, 2016 Phoenix, USA

2

nd

International Conference on

Parkinson’s Disease & Movement Disorders

Rudy Capildeo, J Alzheimers Dis Parkinsonism 2016, 6:6(Suppl)

http://dx.doi.org/10.4172/2161-0460.C1.024

Parkinson’s disease is not a disease

Rudy Capildeo

Nuffield Hospital, UK

S

ince the time of James Parkinson, we have come to recognize a medical condition characterized by the gradual appearance

of stiffness, slowness, reduced mobility, feeling old for one’s years, altered gait with stumbles, and even falls. Tremor is not

always present. Families are often aware of these changes before the patient. At no stage in this condition is there an obvious

illness. Parkinson, in his essay described just six cases. He recognized the slow progress of the condition over many years and

that the clinical signs were asymmetric. Charcot and Gower found no neuropathological changes. Gower famously said “you

do not die from Parkinson’s Disease (PD) but with it”. We recognize “Non-Motor” features of PD, the slow onset of PD over

many years and the positive response of PD to L-Dopa Therapy. PD is now considered to be a disorder of the basal ganglia

and with DAT scanning we can measure dopamine transporter uptake. Qualitative assessment of DAT scans reveals loss of the

“Comma Shape” in PD cases but quantitative measurements reveal an obvious asymmetry in early PD cases. This data will be

presented to show that PD (as opposed to Parkinsonism or PD plus syndromes) is a dopamine deficiency disorder and not a

disease.

Biography

Rudy Capildeo is a Consultant Neurologist who set up one of the first PD clinics in London, UK in 1973 at The Charing Cross Hospital, where he also organized

the first major International PD Symposium in 1979 when Sinemet Plus was first introduced by MSD. He was a Senior Investigator in the 5-year Sinemet CR First

Trial. A frequent presenter in national and international meetings, he continues his interest in PD in his work and in his role as a Teacher.

rcapildeo@uk-consultants.co.uk